Lifecore Biomedical, Inc. De (LFCR) Payables (2011 - 2025)

Lifecore Biomedical's Payables history runs 15 years deep, the most recent figure standing at $8.2 million for Q2 2025.

• In Q2 2025, Payables fell 49.68% year-over-year to $8.2 million; the TTM figure through May 2025 stood at $8.2 million (down 49.68% YoY), while the FY2025 annual figure was $8.2 million, down 49.68% from the prior year.
• Payables was $8.2 million for Q2 2025 at Lifecore Biomedical, up from $7.4 million in the prior quarter.
• In the past five years, Payables ranged from a high of $22.1 million in Q2 2023 to a low of $7.4 million in Q1 2025.
• Historically, Payables has averaged $13.3 million across 5 years, with a median of $13.3 million in 2022.
• The sharpest annual moves came in 2021 and 2023: Payables plunged 86.04% in 2021, then soared 70.61% in 2023.
• A 5-year view of Payables shows it stood at $8.7 million in 2021, then jumped by 53.68% to $13.3 million in 2022, then soared by 43.02% to $19.0 million in 2023, then retreated by 21.32% to $15.0 million in 2024, then slumped by 45.08% to $8.2 million in 2025.
• The last three Payables figures came in at $8.2 million (Q2 2025), $7.4 million (Q1 2025), and $15.0 million (Q4 2024), per Business Quant data.